nach oben

American Journal of Clinical Dermatology

Erschienen in:

16.12.2019 | Review Article

Psoriatic Disease in the US Latino Population: A Comprehensive Review

verfasst von: Alyssa Gwen Ashbaugh, Chloe Ekelem, Yessica Landaverde, Natasha Atanaskova Mesinkovska

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Current evidence suggests that there are notable differences in the severity of psoriasis between racial and ethnic groups. While the US Latino population is growing rapidly, there is little research on the various factors impacting disease severity in this minority population. This review evaluates the current evidence on psoriasis in Latinos within the US. Psoriasis affects the US Latino population at a lower prevalence, with more severe disease and a greater quality-of-life impact than their White counterparts. In addition, Latinos with psoriasis experience higher rates of comorbidities, such as depression, obesity, and diabetes compared with Whites. There is evidence showing non-inferior or better response to systemic treatments, such as etanercept, secukinumab, and brodalumab, in this population. The combination of barriers to care and lack of involvement in research limit the current understanding of the mechanisms responsible for the pathologic outcomes and the environmental and social disparities observed. Future studies that reflect the growing proportion of minorities in the US may help close these knowledge gaps and improve care.

Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70(3):512–6. https://doi.org/10.1016/j.jaad.2013.11.013.CrossRefPubMed

Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol. 2011;65(1):137–74. https://doi.org/10.1016/j.jaad.2010.11.055.CrossRefPubMed

Kaufman BP, Alexis AF. Psoriasis in skin of color: insights into the epidemiology, clinical presentation, genetics, quality-of-life impact, and treatment of psoriasis in non-white racial/ethnic groups. Am J Clin Dermatol. 2018;19(3):405–23. https://doi.org/10.1007/s40257-017-0332-7.CrossRefPubMed

Colby SL, Ortman JM. Projections of the size and composition of the US population: 2014 to 2060. US Department of Commerce: Economics and Statistics Administration: US Census Bureau; 2015. Available at: https://www.census.gov/content/dam/Census/library/publications/2015/demo/p25-1143.pdf. Accessed 1 Nov 2019.

Poon AW, Gray KV, Franco GC, Cerruti DM, Schreck MA, Delgado ED. Cultural competence: serving Latino patients. J Pediatr Orthop. 2003;23(4):546–9.PubMed

US Census Bureau. Hispanic or Latino origin by specific origin. American Community Survey 1-year Estimates. 2016. Available at: https://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?pid=ACS_16_1YR_B03001&prodType=table. Accessed 1 Nov 2019.

Vespa J, Armstrong DM, Medina L. Demographic turning points for the United States: population projections for 2020 to 2060. Current Population Reports. 2018. Available at: https://permanent.access.gpo.gov/gpo93743/P25_1144.pdf. Accessed 1 Nov 2019.

Mitrani V. Reducing health disparities for hispanics through the development of culturally tailored interventions. Hisp Health Care Int. 2009;7(1):2–4. https://doi.org/10.1016/j.asieco.2008.09.006.EAST.CrossRefPubMedPubMedCentral

Moore MM, Sanchez M. Dermatological disease in Latinos in the USA. Expert Rev Dermatol. 2007;2(1):87–100. https://doi.org/10.1586/17469872.2.1.87.CrossRef

10.

Charrow A, Di Xia F, Joyce C, Mostaghimi A. Diversity in dermatology clinical trials a systematic review. JAMA Dermatol. 2017;153(2):193–8. https://doi.org/10.1001/jamadermatol.2016.4129.CrossRefPubMed

11.

Hernández-Vásquez A, Molinari L, Larrea N, Ciapponi A. Psoriasis in Latin America and the Caribbean: a systematic review. J Eur Acad Dermatol Venereol. 2017;31(12):1991–8. https://doi.org/10.1111/jdv.14393.CrossRefPubMed

12.

Raychaudhuri SP, Farber EM. The prevalence of psoriasis in the world. J Eur Acad Dermatol Venereol. 2001;15(1):16–7.CrossRef

13.

Helmick CG, Lee-Han H, Hirsch SC, Baird TL, Bartlett CL. Prevalence of psoriasis among adults in the U.S.: 2003–2006 and 2009–2010 National Health and Nutrition Examination Surveys. Am J Prev Med. 2014;47(1):37–45. https://doi.org/10.1016/j.amepre.2014.02.012.CrossRefPubMedPubMedCentral

14.

Alexis AF, Blackcloud P. Psoriasis in skin of color: epidemiology, genetics, clinical presentation, and treatment nuances. J Clin Aesthet Dermatol. 2014;7(11):16–24.PubMedPubMedCentral

15.

Rochon PA, Mashari A, Cohen A, et al. The inclusion of minority groups in clinical trials: problems of under representation and under reporting of data. Acc Res. 2004;11(3–4):215–23. https://doi.org/10.1080/08989620490891412.CrossRef

16.

Ford ME, Siminoff LA, Pickelsimer E, et al. Unequal burden of disease, unequal participation in clinical trials: Solutions from African American and Latino community members. Health Soc Work. 2013;38(1):29–38. https://doi.org/10.1093/hsw/hlt001.CrossRefPubMedPubMedCentral

17.

Blackwell DL, Lucas JW, Clarke TC. Summary health statistics for U.S. adults: National Health Interview Survey, 2012. National Center for Health Statistics. Vital Health Stat. 2014;10(260):1–161.

18.

Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003–2004. J Am Acad Dermatol. 2009;60(2):218–24. https://doi.org/10.1016/j.jaad.2008.09.022.CrossRefPubMed

19.

Adsit S, Zaldivar ER, Sofen H, et al. Secukinumab is efficacious and safe in hispanic patients with moderate-to-severe plaque psoriasis: pooled analysis of four phase 3 trials. Adv Ther. 2017;34(6):1327–39. https://doi.org/10.1007/s12325-017-0521-z.CrossRefPubMedPubMedCentral

20.

Shah SK, Arthur A, Yang Y-C, Stevens S, Alexis AF. A retrospective study to investigate racial and ethnic variations in the treatment of psoriasis with etanercept. J Drugs Dermatol. 2011;10(8):866–72.PubMed

21.

Robinson JK, Penedo FJ, Hay JL, Jablonski NG. Recognizing Latinos’ range of skin pigment and phototypes to enhance skin cancer prevention. Pigment Cell Melanoma Res. 2017;30(5):488–92. https://doi.org/10.1111/pcmr.12598.CrossRefPubMedPubMedCentral

22.

Yan D, Afifi L, Jeon C, Cordoro KM, Liao W. A cross-sectional study of the distribution of psoriasis subtypes in different ethno-racial groups. Dermatol Online J. 2018;24(7):0–3.

23.

Khalil FK, Keehn CA, Saeed S, Morgan MB. Verrucous psoriasis: a distinctive clinicopathologic variant of psoriasis. Am J Dermatopathol. 2005;27(3):204–7. https://doi.org/10.1097/01.dad.0000157450.39033.31.CrossRefPubMed

24.

Chandran V, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun. 2010;34(3):J314–J321321. https://doi.org/10.1016/j.jaut.2009.12.001.CrossRefPubMed

25.

Raychaudhuri SP, Gross J. Psoriasis risk factors: role of lifestyle practices. Cutis. 2000;66(5):348–52.PubMed

26.

Centers for Disease Control and Prevention. HIV Surveillance Report. 2016. Available at: https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2016-vol-28.pdf. Accessed 1 Nov 2019.

27.

Stepler R, Hugo Lopez M. U.S. Latino Population Growth and Dispersion Has Slowed Since Onset of the Great Recession. 2016. Available at: https://www.pewresearch.org/hispanic/2016/09/08/latino-population-growth-and-dispersion-has-slowed-since-the-onset-of-the-great-recession/. Accessed 1 Nov 2019.

28.

Zink A, Herrmann M, Fischer T, et al. Addiction: an underestimated problem in psoriasis health care. J Eur Acad Dermatol Venereol. 2017;31(8):1308–15. https://doi.org/10.1111/jdv.14204.CrossRefPubMed

29.

Chartier K, Caetano R. Ethnicity and health disparities in alcohol research. Alcohol Res Health. 2010;33(1–2):152–60.PubMedPubMedCentral

30.

Wang TW, Husten CG, Corey CG, et al. Tobacco product use among adults-United States, 2015. Morb Mortal Wkly Rep. 2017;67(44):1225–322. https://doi.org/10.15585/mmwr.mm6644a2.CrossRef

31.

Yan D, Afifi L, Jeon C, Cordoro KM, Liao W. A cross-sectional study of psoriasis triggers among different ethno-racial groups. J Am Acad Dermatol. 2017;77(4):756–758.e1. https://doi.org/10.1016/j.jaad.2017.04.1109.CrossRefPubMedPubMedCentral

32.

Moy JA, McKinley-Grant L, Sanchez MR. Cultural aspects in the treatment of patients with skin disease. Dermatol Clin. 2003;21(4):733–42. https://doi.org/10.1016/S0733-8635(03)00088-3.CrossRefPubMed

33.

Bajaj S, Wolner ZJ, Dusza SW, Braun RP, Marghoob AA, DeFazio J. Total body skin examination practices: a survey study amongst dermatologists at high-risk skin cancer clinics. Dermatol Pract Concept. 2019;9(2):132–8. https://doi.org/10.5826/dpc.0902a09.CrossRefPubMedPubMedCentral

34.

Dhana A, Yen H, Yen H, Cho E. All-cause and cause-specific mortality in psoriasis: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(5):1332–433. https://doi.org/10.1016/j.jaad.2018.12.037.CrossRefPubMed

35.

Centers for Disease Control and Prevention (CDC). Access to health-care and preventive services among Hispanics and non-Hispanics—United States, 2001–2002. MMWR Morb Mortal Wkly Rep. 2004;53(40):937–41.

36.

Abrouk M, Lee K, Brodsky M, et al. Ethnicity affects the presenting severity of psoriasis. J Am Acad Dermatol. 2017;77(1):180–2. https://doi.org/10.1016/j.jaad.2017.02.042.CrossRefPubMed

37.

Buster KJ, Stevens EI, Elmets CA. dermatologic health disparities. Dermatol Clin. 2012;30(1):53–9. https://doi.org/10.1016/j.det.2011.08.002.CrossRefPubMedPubMedCentral

38.

Gloster HM, Neal K. Skin cancer in skin of color. J Am Acad Dermatol. 2006;55(5):741–60. https://doi.org/10.1016/j.jaad.2005.08.063.CrossRefPubMed

39.

Institute for Health Metrics and Evaluation. The Global Burden of Disease: Generating Evidence, Guiding Policy. 2013. Available at: https://www.healthdata.org/sites/default/files/files/policy_report/2013/GBD_GeneratingEvidence/IHME_GBD_GeneratingEvidence_FullReport.pdf. Accessed 1 Nov 2019.

40.

Escarce JJ, Kapur K. Hispanics and the future of America: access to and quality of health care. Washington, DC: The National Academies Press; 2006.

41.

World Health Organization (WHO). Global report on psoriasis. 2016. Available at: https://apps.who.int/iris/bitstream/handle/10665/204417/9789241565189_eng.pdf?sequence=1&isAllowed=y. Accessed 1 Nov 2019.

42.

Goff KL, Karimkhani C, Boyers LN, et al. The global burden of psoriatic skin disease. Br J Dermatol. 2015;172(6):1665–8. https://doi.org/10.1111/bjd.13715.CrossRefPubMed

43.

Cohen BE, Martires KJ, Ho RS. Psoriasis and the risk of depression in the US population national health and nutrition examination survey 2009–2012. JAMA Dermatol. 2016;152(1):73–9. https://doi.org/10.1001/jamadermatol.2015.3605.CrossRefPubMed

44.

McMichael A, Desai SR, Qureshi A, Rastogi S, Alexis AF. Efficacy and safety of brodalumab in patients with moderate-to-severe plaque psoriasis and skin of color: results from the pooled AMAGINE-2/-3 randomized trials. Am J Clin Dermatol. 2019;20(2):267–76. https://doi.org/10.1007/s40257-018-0408-z.CrossRefPubMed

45.

Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58(5):826–50. https://doi.org/10.1016/j.jaad.2008.02.039.CrossRefPubMed

46.

Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017;76(3):377–90. https://doi.org/10.1016/j.jaad.2016.07.064.CrossRefPubMedPubMedCentral

47.

Young KL, Graff M, Fernandez-Rhodes L, North KE. Genetics of obesity in diverse populations. Curr Diab Rep. 2018;18(12):145. https://doi.org/10.1007/s11892-018-1107-0.CrossRefPubMedPubMedCentral

48.

National Center for Health Statistics. Health, United States, 2016: With Chartbook on Long-term Trends in Health. 2017. Available at: https://www.cdc.gov/nchs/data/hus/hus16.pdf. Accessed 1 Nov 2019.

49.

Gelfand JM, Gladman DD, Mease PJ, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol. 2005;53(4):573–7. https://doi.org/10.1016/j.jaad.2005.03.046.CrossRefPubMed

50.

Boehncke W-H, Menter A. Burden of disease: psoriasis and psoriatic arthritis. Am J Clin Dermatol. 2013;14(5):377–88. https://doi.org/10.1007/s40257-013-0032-x.CrossRefPubMed

51.

Gottlieb A, Korman NJ, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008;58(5):851–64. https://doi.org/10.1016/j.jaad.2008.02.040.CrossRefPubMed

52.

Leung YY, Fong W, Lui NL, Thumboo J. Effect of ethnicity on disease activity and physical function in psoriatic arthritis in a multiethnic Asian population. Clin Rheumatol. 2017;36(1):125–31. https://doi.org/10.1007/s10067-016-3460-1.CrossRefPubMed

53.

Yeung H, Takeshita J, Mehta NN, et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol. 2013;149(10):1173–9. https://doi.org/10.1001/jamadermatol.2013.5015.CrossRefPubMedPubMedCentral

54.

Shah K, Mellars L, Changolkar A, Feldman SR. Real-world burden of comorbidities in US patients with psoriasis. J Am Acad Dermatol. 2017;77(2):287–292.e4. https://doi.org/10.1016/j.jaad.2017.03.037.CrossRefPubMed

55.

Carroll MD, Kit BK, Lacher DA, Yoon SS. Total and high-density lipoprotein cholesterol in adults: National Health and Nutrition Examination Survey, 2011–2012. NCHS Data Brief. 2013;10(132):1–8.

56.

Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National and Health and Nutrition Examination Survey, 2011–2012. NCHS Data Brief. 2013;133:1–8. https://doi.org/10.1017/CBO9781107415324.004.CrossRef

57.

Nieves-Rivera J, Sulia C, Gonzalez R, et al. Psoriasis and coronary artery disease in hispanics. Bol Asoc Med P R. 2016;108(2):65–7.PubMed

58.

Kwa L, Kwa MC, Silverberg JI. Cardiovascular comorbidities of pediatric psoriasis among hospitalized children in the United States. J Am Acad Dermatol. 2017;77(6):1023–9. https://doi.org/10.1016/j.jaad.2017.08.034.CrossRefPubMedPubMedCentral

59.

Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States. Available at: https://doi.org/10.1177/1527154408322560

60.

Schneiderman N, Llabre M, Cowie CC, et al. Prevalence of diabetes among Hispanics/Latinos from diverse backgrounds: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Diabetes Care. 2014;37(8):2233–9. https://doi.org/10.2337/dc13-2939.CrossRefPubMedPubMedCentral

61.

Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United States, 2011–2014. NCHS Data Brief. 2015;219:1–8. https://doi.org/10.1017/S1368980017000088.CrossRef

62.

Langan SM, Seminara NM, Shin DB, et al. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Investig Dermatol. 2012;132(3 Pt 1):556–62. https://doi.org/10.1038/jid.2011.365.CrossRefPubMed

63.

Gelfand JM. Psoriasis, type 2 diabetes mellitus, and obesity. JAMA Dermatol. 2016;152(7):753. https://doi.org/10.1001/jamadermatol.2016.0670.CrossRefPubMedPubMedCentral

64.

Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146(8):891–5. https://doi.org/10.1001/archdermatol.2010.186.CrossRefPubMedPubMedCentral

65.

Schmitt J, Ford DE. Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis—a structural equations modeling approach. Gen Hosp Psychiatry. 2007;29(2):134–40. https://doi.org/10.1016/j.genhosppsych.2006.12.004.CrossRefPubMed

66.

Pratt LA, Brody DJ. Depression in the U.S. household population, 2009–2012. NCHS Data Brief. 2014;172:1–8.

67.

Golbari NM, Lockwood SJ, Porter ML, Kimball AB. Understanding patient engagement in psoriasis treatment. Br J Dermatol. 2018;178(4):988–9. https://doi.org/10.1111/bjd.16266.CrossRefPubMed

68.

Risser AL, Mazur LJ. Use of folk remedies in a Hispanic population. Arch Pediatr Adolesc Med. 1995;149(9):978–81. https://doi.org/10.1001/archpedi.1995.02170220044006.CrossRefPubMed

69.

Ransford HE, Carrillo FR, Rivera Y. Health care-seeking among Latino immigrants: blocked access, use of traditional medicine, and the role of religion. J Health Care Poor Underserved. 2010;21(3):862–78. https://doi.org/10.1353/hpu.0.0348.CrossRefPubMed

70.

Valdez RB, Giachello A, Rodriguez-Trias H, Gomez P, De la Rocha C. Improving access to health care in Latino communities. Public Health Rep. 1993;108(5):534–9.PubMedPubMedCentral

71.

Caballero AE. Understanding the Hispanic/Latino patient. Am J Med. 2011;124(10 Suppl):S10–S1515. https://doi.org/10.1016/j.amjmed.2011.07.018.CrossRefPubMed

72.

Seijo R, Gomez H, Freidenberg J. Language as a communication barrier in medical care for hispanic patients. Hisp J Behav Sci. 1991;13(4):363–76.CrossRef

73.

Radford J, Noe-Bustamante L. Facts on U.S. Immigrants, 2017: Statistical portrait of the foreign-born population in the United States. Pew Research Center. 2019. Available at: https://www.pewresearch.org/hispanic/2019/06/03/facts-on-u-s-immigrants/. Accessed 13 Oct 2019.

74.

Harvey VM. Racial and ethnic disparities in dermatology office visits among insured patients, 2005–2010. J Health Dispar Res Pract. 2016;9(2):93–131.

75.

Pitkin Derose K, Bahney BW, Lurie N, Escarce JJ. Review: immigrants and health care access, quality, and cost. Med Care Res Rev. 2009;66(4):355–408. https://doi.org/10.1177/1077558708330425.CrossRef

76.

Halder RM, Nootheti PK. Ethnic skin disorders overview. J Am Acad Dermatol. 2003;48(6 SUPPL.):143–8. https://doi.org/10.1067/mjd.2003.274.CrossRef

77.

Tyring S, Mendoza N, Appell M, et al. A calcipotriene/betamethasone dipropionate two-compound scalp formulation in the treatment of scalp psoriasis in Hispanic/Latino and Black/African American patients: results of the randomized, 8-week, double-blind phase of a clinical trial. Int J Dermatol. 2010;49(11):1328–33. https://doi.org/10.1111/j.1365-4632.2010.04598.x.CrossRefPubMed

78.

Bureau of Labor Statistics USD of L. Unemployment rate and employment-population ratio vary by race and ethnicity. The Economics Daily; 2017. Available at: https://www.bls.gov/opub/ted/2017/unemployment-rate-and-employment-population-ratio-vary-by-race-and-ethnicity.htm#bls-print. Accessed 1 Nov 2019.

79.

Vega WA, Rodriguez MA, Gruskin E. Health disparities in the latino population. Epidemiol Rev. 2009;31(1):99–112. https://doi.org/10.1093/epirev/mxp008.CrossRefPubMedPubMedCentral

80.

Gándara P. The Latino Education Crisis.: EBSCOhost. Educational Leadership; 2010. Available at: https://www.ascd.org/publications/educational-leadership/feb10/vol67/num05/The-Latino-Education-Crisis.aspx. Accessed 1 Nov 2019.

81.

Calvo R. Health literacy and quality of care among Latino Immigrants in the United States. Health Soc Work. 2014;41(1):e44–e51. https://doi.org/10.1093/hsw/hlv076.CrossRef

Titel: Psoriatic Disease in the US Latino Population: A Comprehensive Review
verfasst von: Alyssa Gwen Ashbaugh
Chloe Ekelem
Yessica Landaverde
Natasha Atanaskova Mesinkovska
Publikationsdatum: 16.12.2019
Verlag: Springer International Publishing
Erschienen in: American Journal of Clinical Dermatology / Ausgabe 2/2020
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI: https://doi.org/10.1007/s40257-019-00498-8

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

16.04.2024 DGIM 2024 Nachrichten

Den Reflex, eine oberflächliche chronische Hautwunde ohne Entzündungszeichen in jedem Fall abzustreichen, sollte man nach einer neuen „Klug-entscheiden“-Empfehlung unterdrücken.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2020

Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)

Diabetic Foot Ulcers: Appraising Standard of Care and Reviewing New Trends in Management

Retrospective Case Series on Risk Factors, Diagnosis and Treatment of Pseudomonas aeruginosa Nail Infections

Oral Spironolactone for Acne Vulgaris in Adult Females: An Update of the Literature

Malignant Melanoma of the Vulva and Vagina: A US Population-Based Study of 1863 Patients

Laser and Light-Based Treatment Modalities for the Management of Hidradenitis Suppurativa